Trials and PIs
View all posts »PEARL HF with Dr Bertram Pitt
Aug 29, 2010 09:55 EDT-
1Comments
-
Read later
Dr Bertram Pitt (University of Michigan, Ann Arbor) discusses PEARL HF: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of RLY5016 in heart-failure patients.
Recorded at the ESC convention center in Stockholm, Sweden on Sunday, August 29.
See:
PEARL-HF: New potassium-binding resin reduces hyperkalemia in heart failure
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
